Long-acting injectable paliperidone palmitate in a haemodialysis patient with schizophrenia

被引：0
|
作者：
Lin, Jia-Hong [1 ]
Tsai, Tsung-Huang [2 ]
Lee, Chia-Shun [2 ]
Yang, Ya-Hui [2 ]
Chen, Kuang-Peng [2 ]
Tung, Chun-Liong [2 ]
Tsai, Jui-Hsiu [2 ,3 ,4 ]
机构：
[1] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Internal Med, Chiayi, Taiwan
[2] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Psychiat, 2 Min Sheng Rd, Chiayi 622, Taiwan
[3] Natl Hlth Res Inst, PhD Program Environm & Occupat Med, Kaohsiung, Taiwan
[4] Kaohsiung Med Univ, Kaohsiung, Taiwan
来源：
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY | 2021年 / 55卷 / 08期
关键词：
D O I：
10.1177/0004867420952548
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：829 / 830
页数：2
相关论文
共 50 条
  • [31] Bilateral Pretibial Edema Associated with Paliperidone Palmitate Long-acting Injectable: A Case Report
    Cicek, Erdinc
    Cicek, Ismet Esra
    Uguz, Faruk
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2017, 15 (02) : 184 - 186
  • [32] Cost minimization analysis comparing paliperidone palmitate with risperidone long-acting injectable in Spain
    Quintero, I.
    Gonzalez, B.
    Garcia, I.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 50 - 50
  • [33] Clinical Pharmacology of Paliperidone Palmitate A Parenteral Long-Acting Formulation for the Treatment of Schizophrenia
    Gilday, Elizabeth
    Nasrallah, Henry A.
    REVIEWS ON RECENT CLINICAL TRIALS, 2012, 7 (01) : 2 - 9
  • [34] Paliperidone palmitate and risperidone long-acting injectable in subjects with schizophrenia recently treated with oral risperidone or other oral antipsychotics
    Alphs, Larry
    Bossie, Cynthia A.
    Sliwa, Jennifer Kern
    Fu, Dong-Jing
    Ma, Yi-Wen
    Hulihan, Joseph
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2013, 9 : 341 - 350
  • [35] Healthcare resource utilization of second-generation long-acting injectable antipsychotics in schizophrenia: risperidone versus paliperidone palmitate
    Joshi, Kruti
    Pan, Xiaoyun
    Wang, Rosa
    Yang, Erru
    Benson, Carmela
    CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (11) : 1873 - 1881
  • [36] COST EFFECTIVENESS OF PALIPERIDONE PALMITATE VERSUS RISPERIDONE LONG-ACTING INJECTABLE, QUETIAPINE AND OLANZAPINE FOR THE TREATMENT OF PATIENTS WITH SCHIZOPHRENIA IN COLOMBIA
    Casallas, C.
    Ariza, J. G.
    VALUE IN HEALTH, 2013, 16 (07) : A695 - A695
  • [37] Role of 3-monthly long-acting injectable paliperidone in the maintenance of schizophrenia
    Brasso, Claudio
    Bellino, Silvio
    Bozzatello, Paola
    Montemagni, Cristiana
    Rocca, Paola
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2017, 13 : 2767 - 2779
  • [38] Obsessive-compulsive symptoms induced by long-acting injectable paliperidone in a patient with schizophrenia: A case report
    Vazquez-Bourgon, Javier
    Rodriguez-Rodriguez, Pablo
    Gomez-Ruiz, Elsa
    Artal, Jesus
    Crespo-Facorro, Benedicto
    ANNALS OF CLINICAL PSYCHIATRY, 2014, 26 (04) : 301 - 302
  • [39] Paliperidone palmitate long-acting injection in schizophrenic patients
    Suarez Gisbert, E.
    EUROPEAN PSYCHIATRY, 2020, 63 : S540 - S540
  • [40] Paliperidone palmitate long-acting injectable delays psychotic and mood symptom relapse in schizoaffective disorder
    Fu, D. J.
    Alphs, L.
    Lindenmayer, J. P.
    Schooler, N.
    Simonson, R. B.
    Turkoz, I.
    Walling, D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S534 - S535
12345